{"database": "lobbying", "table": "lobbying_activities", "rows": [[2102543, "40ae77a2-61f3-4e92-889c-c90dad2c92f0", "Q1", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2018, "first_quarter", "MMM", "H.R. 1625/PL 115-141 - Consolidated Appropriations Act of 2018 - Issues related to access and affordability of prescription medications and policies to combat the opioid crisis in the United States. \n\nH.R. 1301/PL 115-124 - Continuing Resolution of 2018 - Issues related access and affordability of prescription medications in the United States, treatment of biosimilars and generics in public and private insurance and policies to combat the opioid crisis in the United States. \n\nCMS Regulations related to the Medicare Part D program and Prescription Drug Plans (PDPs)\n\nS. 637 - Creating Transparency to Have Prescription Drug Rebates Unlocked - Issues related to the alleged relationship between rebates and drug prices. \n\nS. 771 - A Bill to Improve Access to Affordable Prescription Drugs - Issues related to bringing drug prices down including strengthening policies in the Part D coverage gap, couponing and advancing biosimilars. \n\nEducation activities for Members and staff related to Direct and Indirect Renumeration(DIR)policies. \n\nEducation activities related to the cross referencing of certain data related to Medicare Parts A, B and D. \n\nIssues related to lowering the cost of prescription medications in the Medicare and Medicaid programs.", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", 60000, null, 0, 0, "2018-04-06T15:08:50.833000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2102543"], "units": {}, "query_ms": 10.480227996595204, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}